Received Jun 9, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TL74Y | — |
Administration after Below temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 50-year-old female patient who received Herpes zoster (Shingrix) solution for injection (batch number TL74Y) for prophylaxis. On 19-MAY-2026, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: Administration after Below temperature excursion). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 04-JUN-2026 The reporter reported that an excursion for Shingrix (PFS) vaccines with a minute temperature of 30 degrees Fahrenheit, for 2 hours. The reporter was asking if the patient needs to be revaccinated. The patient received Shingrix on 19-MAY-2026. This was the report 11 of 19 patients reported by the same reporter.; Sender's Comments: US-GSK-US2026074480:SAME REPORTER US-GSK-US2026074479:SAME REPORTER US-GSK-US2026074478:SAME REPORTER US-GSK-US2026074487:SAME REPORTER US-GSK-US2026074488:SAME REPORTER US-GSK-US2026074480:SAME REPORTER US-GSK-US2026074475:SAME REPORTER US-GSK-US2026074484:SAME REPORTER US-GSK-US2026074485:SAME REPORTER US-GSK-US2026074486:SAME REPORTER US-GSK-US2026074481:SAME REPORTER US-GSK-US2026074476:SAME REPORTER US-GSK-US2026074706:SAME REPORTER US-GSK-US2026074489:SAME REPORTER US-GSK-US2026074749:SAME REPORTER US-GSK-US2026074882:SAME REPORTER US-GSK-US2026075045:SAME REPORTER US-GSK-US2026074706:SAME REPORTER